{"disease":{"id":"dialysis-dependent-chronic-kidney-disease","name":"dialysis dependent chronic kidney disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03439137","title":"Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT03329196","title":"Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT06477978","title":"The Prevalence of Sarcopenia in a Cohort of Haemodialysis Patients and Its Correlation With Mortality","phase":"NA","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false},{"nct_id":"NCT03903809","title":"Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":175,"lead_sponsor_name":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03799627","title":"Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Akebia Therapeutics","has_results":true},{"nct_id":"NCT07414199","title":"The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Children's Hospital of Orange County","has_results":false},{"nct_id":"NCT03402386","title":"Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT07459348","title":"Can Changes in Dialysate Sodium Concentration Improve Blood Pressure and Endothelial Function in Chronic HD Patients?","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Gødstrup Hospital","has_results":false},{"nct_id":"NCT03461146","title":"Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT01155388","title":"A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"AMAG Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03140722","title":"Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Akebia Therapeutics","has_results":true}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}